RAPP Rapport Therapeutics, Inc.
$43.62▲ +0.37%
Healthcare
Other
After hours
$43.62▲ +0.00%
Sep 11, 7:30 PM ET
Volume 251.8K
Avg Volume (10D) 318.3K
Key Metrics & Fundamentals
Market Cap
$2.09B
P/E Ratio
–
Div Yield
–%
52W Range
22.73 - 52.93
% vs 50 MA
-2.37%
% vs 200 MA
23.89%
RSI-14
38.6
MACD Histogram
-0.9600
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$41.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$60.59M
COGS
–
Operating Exp
$60.81M
Operating Income
-$60.81M
EBIT
-$60.81M
Pretax Income
-$56.62M
Net Income
-$56.62M
EPS (Diluted)
-1.19
Price & Volume History
Loading chart…
Recent News
Rapport Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 11:00 AM
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
GlobeNewswire · Aug 24, 2026 11:00 AM
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update
GlobeNewswire · Aug 5, 2026 11:00 AM
William Blair Initiates Rapport Therapeutics at Outperform
MT Newswires · Jul 28, 2026 11:23 AM
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
Motley Fool · Jul 12, 2026 11:53 PM
Leerink Partners Initiates Rapport Therapeutics at Outperform With $52 Price Target
MT Newswires · Jun 24, 2026 11:37 AM
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
Insider Monkey · Jun 16, 2026 3:08 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See RAPP's money flow as a full page
Social Sentiment
No Reddit posts found for RAPP.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.